Perfusion Index Changes in Cardiovascular Autonom Neuropathia Type-2 Dm Whit Spinal Anesthesia

Study Overview
=================
Brief Summary
-----------------
Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardiac sympathetic and parasympathetic innervation disturbances, qt interval prolongation and sudden deaths observed. The purpose of this study is to evaluate the relationship between cardiovascular autonomic neuropathy and perfusion index in spinal anesthesia

Detailed Description
-----------------
Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardiac sympathetic and parasympathetic innervation disturbances, qt interval prolongation and sudden deaths observed. The purpose of this study is to evaluate the relationship between cardiovascular autonomic neuropathy and perfusion index in spinal anesthesia

Official Title
-----------------
Observational Study Relationship Between Perfusion Index Changes and Intraoperative Complications in Cardiovascular Autonom Neuropathia Type-2 DM Patients With Spinal Anesthesia

Conditions
-----------------
Anesthesia; Adverse Effect

Intervention / Treatment
-----------------
* Device: perfusion index monitor
* Diagnostic Test: ewing test


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: the patient will be operated with spinal anesthesia over 18 years no additional disease and only DM Exclusion Criteria: patients with additional disease patients under 18 years of age patients contraindicated in spinal anesthesia

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| control group<br>no additional disease | Device: perfusion index monitor<br>* perfusion index measured in patients undergoing spinal anesthesia with non-invasive perfusion index monitor<br>|
| working group-1<br>additional disease only DM and no cardıovascular autonomous neuropathıa | Device: perfusion index monitor<br>* perfusion index measured in patients undergoing spinal anesthesia with non-invasive perfusion index monitor<br>Diagnostic Test: ewing test<br>* ewing tests will be applied to diabetic patients undergoing spinal anesthesia for cardıovascular autonomous neuropathıa diagnosis<br>|
| working group-2<br>additional disease only DM and pozitif cardıovascular autonomous neuropathıa | Device: perfusion index monitor<br>* perfusion index measured in patients undergoing spinal anesthesia with non-invasive perfusion index monitor<br>Diagnostic Test: ewing test<br>* ewing tests will be applied to diabetic patients undergoing spinal anesthesia for cardıovascular autonomous neuropathıa diagnosis<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Perfusion index change | Perfusion index change in spinal anesthesia related cardiovascular autonom neuropatia | Day 1 |